Effects of Lifestyle Intervention Performed by Community Pharmacists on Glycemic Control in Patients with Type 2 Diabetes: The Community Pharmacists Assist (Compass) Project, a Pragmatic Cluster Randomized Trial
- 1 Department of Preventive Medicine, Clinical Research Institute for Endocrine and Metabolic Disease, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
- 2 Clinical Laboratory of Practical Pharmacy, Osaka University of Pharmaceutical Sciences, Osaka, Japan
- 3 Clinical Laboratory of Practical Pharmacy, Osaka University of Pharmaceutical Sciences, Osaka, Japan
- 4 Division of Community and Family Medicine, Jichi Medical University, Tochigi, Japan
- 5 Department of Health Informatics, Kyoto University School of Public Health, Kyoto, Japan
- 6 Polon Company, Kobe, Japan
- 7 Department of Preventive Medicine, Clinical Research Institute for Endocrine and Metabolic Disease, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
Abstract
Background: Community pharmacists should be involved in diabetes care, while there has been less evidence about whether a brief lifestyle intervention is effective for diabetes care in community pharmacies. Objectives: To examine the effects of brief lifestyle intervention on glycemic control in patients with type 2 diabetes mellitus (T2D) by using a coaching style, provided by community pharmacists. Methods: A prospective, cluster-randomized, controlled trial was conducted in 50 groups of community pharmacies in Japan. In all, 132 patients with T2D (age, 20 - 75 years, ≥8.0% of hemoglobin A1c (HbA1c)) were assigned to the intervention group (n = 90) or the usual care group (n = 42). The intervention group (IG) underwent brief lifestyle coaching for self-care of T2D for 6 months. The standard care group (CG) received usual care by pharmacists and was given a general newsletter. The primary outcome was changes in HbA1c levels. Results: After 6 months, the IG had significantly improved HbA1c (IG: -0.6 ± 0.9 vs. CG: -0.2% ± 0.9%; p = 0.021 using the last observation carried forward analysis). Although the number of drugs reduced from 2.3 ± 0.8 to 2.0 ± 1.2 in the IG, the number increased from 2.3 ± 1.1 to 2.5 ± 1.1 in the CG (-0.2 ± 0.9 in IG vs. 0.2 ± 0.6 in CG; p = 0.023). Conclusions: The brief lifestyle intervention by community pharmacists improved glycemic control in patients with T2D. Community pharmacists may more positively participate as lifestyle coaches for diabetes care.
- Chen, L., Magliano, D.J. and Zimmet, P.Z. (2011) The Worldwide Epidemiology of Type 2 Diabetes Mellitus-Present and Future Perspectives. Nature Reviews Endocrinology, 8, 228-236. http://dx.doi.org/10.1038/nrendo.2011.183
- International Diabetes Federation: IDF Diabetes Atlas Sixth Edition 2013. https://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf
- National Institute of Health and Nutrition, Section of the National Health and Nutrition Survey. http://www0.nih.go.jp/eiken/english/research/project_nhns.html
- UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive Blood-Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33). Lancet, 12, 837-853.
- Wake, N., Hisashige, A., Katayama, T., Kishikawa, H., Ohkubo, Y., Sakai, M., Araki, E. and Shichiri, M. (2000) Cost-Effectiveness of Intensive Insulin Therapy for Type 2 Diabetes: A 10-Year Follow-Up of the Kumamoto Study. Diabetes Research and Clinical Practice, 48, 201-210. http://dx.doi.org/10.1016/S0168-8227(00)00122-4
- Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N. and Shichiri, M. (1995) Intensive Insulin Therapy Prevents the Progression of Diabetic Microvascular Complications in Japanese Patients with Non-Insulin-Dependent Diabetes Mellitus: A Randomized Prospective 6-Year Study. Diabetes Research and Clinical Practice, 28, 103-117. http://dx.doi.org/10.1016/0168-8227(95)01064-K
- Eades, C.E., Ferguson, J.S. and O’Carroll, R.E. (2011) Public Health in Community Pharmacy: A Systematic Review of Pharmacist and Consumer Views. BMC Public Health, 21, 582.
- Twigg, M.J., Poland, F., Bhattacharya, D., Desborough, J.A. and Wright, D.J. (2013) The Current and Future Roles of Community Pharmacists: Views and Experiences of Patients with Type 2 Diabetes. Research in Social Administrative Pharmacy, 9, 777-789. http://dx.doi.org/10.1016/j.sapharm.2012.10.004
- Cranor, C.W., Bunting, B.A. and Christensen, D.B. (2003) The Asheville Project: Long-Term Clinical and Economic Outcomes of a Community Pharmacy Diabetes Care Program. Journal of the American Pharmaceutical Association, 43, 173-184. http://dx.doi.org/10.1331/108658003321480713
- Fera, T., Bluml, B.M. and Ellis, W.M. (2009) Diabetes Ten City Challenge: Final Economic and Clinical Results. Journal of the American Pharmaceutical Association, 49, 383-391. http://dx.doi.org/10.1331/JAPhA.2009.09015